Skip to main content
. Author manuscript; available in PMC: 2010 Dec 22.
Published in final edited form as: Cell Cycle. 2010 Apr 1;9(7):1411–1420. doi: 10.4161/cc.9.7.11255

Figure 1.

Figure 1

Inhibition of MDM2 activates p53 in TGCT cells. Cells treated with 5 µM Nutlin (A) or 4 µM cisplatin (B) for 18 hrs were analyzed by western blot for indicated markers.